Symptom checker
Select audience type

Switch between content for healthcare professionals (PRO) and general audience (GEN).

ADD CONDITION

items per page

Childrens Antacid

Last content change checked dailysee data sync status

Active ingredient
Calcium Carbonate 400 mg
Other brand names
Drug classes
Blood Coagulation Factor, Phosphate Binder
Dosage form
Tablet, Chewable
Route
Oral
Prescription status
OTC (over the counter)
Pregnancy
See Pregnancy Use Section
Lactation
See Lactation Use Section
Marketed in the U.S.
Since 2023
Label revision date
June 7, 2025
Drug Information (PDF)
Prescribing information, PDF file
Active ingredient
Calcium Carbonate 400 mg
Other brand names
Drug classes
Blood Coagulation Factor, Phosphate Binder
Dosage form
Tablet, Chewable
Route
Oral
Prescription status
OTC (over the counter)
CSA schedule
Not a scheduled drug
Pregnancy
See Pregnancy Use Section
Lactation
See Lactation Use Section
Marketed in the U.S.
Since 2023
Label revision date
June 7, 2025
Manufacturer
DOLGENCORP, LLC
Registration number
M001
NDC root
55910-590
Drug Information (PDF)
Prescribing information, PDF file
Packaging Info
Packaging & NDC Codes

If you are a healthcare professional or from the pharmaceutical industry please visit this version.

If you are a consumer or patient please visit this version.

Drug Overview

DG™ | health is a children's antacid that contains calcium carbonate (a substance that helps neutralize stomach acid) in chewable tablet form. Each tablet is designed to relieve common digestive discomforts such as acid indigestion, heartburn, sour stomach, and upset stomach associated with these symptoms.

These chewable tablets come in a pleasant bubble gum flavor, making them more appealing for kids. They are an alternative to other children's antacids, like Pepto® Kids Chewables, and are available in a pack of 24 tablets.

Uses

If you're experiencing discomfort from heartburn, acid indigestion, or a sour stomach, this medication can help relieve those symptoms. It’s also effective for an upset stomach that comes along with these issues.

You can feel confident using this medication, as there are no known teratogenic effects (which means it doesn't cause birth defects) associated with it.

Dosage and Administration

To determine the right dose for you or your child, first check the dosing chart based on weight, which is preferred, or age if weight isn’t available. For children aged 2 to 5 years who weigh between 24 and 47 pounds, the recommended dose is 1 chewable tablet. For those aged 6 to 11 years who weigh between 48 and 95 pounds, the dose is 2 chewable tablets. If your child is under 2 years old and weighs less than 24 pounds, please consult a doctor for guidance.

When taking the chewable tablets, make sure to chew or crush them completely before swallowing; do not swallow them whole. You can repeat the dose as needed, but be cautious not to exceed the maximum limit of 3 chewable tablets for children aged 2 to 5 or 6 chewable tablets for those aged 6 to 11 within a 24-hour period. Additionally, do not use the maximum dosage for more than two weeks unless directed by a doctor.

What to Avoid

It's important to be aware of certain guidelines when using this medication. While there are no specific contraindications or concerns about abuse, misuse, or dependence, you should stop using the medication and consult your doctor if your symptoms persist for more than two weeks. This ensures that you receive the appropriate care and support for your health needs. Always prioritize your well-being and seek professional advice when necessary.

Side Effects

Before using this medication, it's important to consult with a doctor or pharmacist, especially if your child is currently taking any prescription drugs, as antacids can interact with some of them. If symptoms persist for more than two weeks, you should stop using the medication and seek medical advice.

Always keep this and all medications out of the reach of children to ensure their safety.

Warnings and Precautions

Before using this medication, it's important to consult with your doctor or pharmacist, especially if your child is currently taking any prescription drugs, as antacids can interact with certain medications.

If your symptoms persist for more than two weeks, you should stop taking the medication and reach out to your doctor for further advice. While there are no specific emergency instructions provided, always seek immediate medical help if you experience severe or concerning symptoms.

Overdose

If you suspect an overdose, it's important to stay calm and take immediate action. While there is no specific information available about the signs of overdose for this medication, general symptoms can include unusual drowsiness, confusion, or difficulty breathing. If you notice any of these signs or feel unwell after taking the medication, seek medical help right away.

In case of an overdose, contact your healthcare provider or local emergency services immediately. They can provide the necessary assistance and guidance. Always remember that it's better to be safe and get checked if you have any concerns about your health.

Pregnancy Use

If you are pregnant or planning to become pregnant, it's important to be aware that there is no specific information available about the use of this medication during pregnancy. This means that safety concerns, dosage adjustments, or any special precautions have not been established.

Before taking this medication, you should consult with your healthcare provider to discuss any potential risks and to ensure that you are making informed decisions for your health and the health of your baby. Always prioritize open communication with your doctor regarding any medications you may be considering during pregnancy.

Lactation Use

When it comes to breastfeeding, it's important to be aware that there is no specific information available regarding the use of this medication for nursing mothers or during lactation (the period of breastfeeding). This means that if you are breastfeeding, you should consult your healthcare provider for personalized advice and to discuss any potential risks or concerns related to your situation. Always prioritize your health and the well-being of your baby by seeking guidance from a medical professional.

Pediatric Use

Before giving this medication to your child, it's important to consult with a doctor or pharmacist, especially if they are currently taking any prescription drugs, as some medications can interact with antacids. If your child's symptoms persist for more than two weeks, stop using the medication and seek medical advice. Always keep this and all medications out of reach of children.

When determining the right dose for your child, refer to their weight for the most accurate measurement. For children aged 2-5 years who weigh between 24-47 pounds, the recommended dose is 1 chewable tablet. For those aged 6-11 years weighing between 48-95 pounds, the dose is 2 chewable tablets. Remember, children should chew or crush the tablets completely before swallowing and should not exceed 3 tablets in a 24-hour period for ages 2-5, or 6 tablets for ages 6-11. It's also advised not to use this medication for more than two weeks unless directed by a doctor.

Geriatric Use

When it comes to using this medication in older adults, there is no specific information available about dosage adjustments, safety concerns, or special precautions. This means that if you or a loved one is an older adult, it’s important to consult with a healthcare provider before starting the medication. They can help determine the best approach based on individual health needs and any other medications being taken. Always prioritize open communication with your healthcare team to ensure safe and effective treatment.

Renal Impairment

If you have kidney problems, it's important to know that there are no specific guidelines or dosage adjustments mentioned for your condition in the available information. This means that the usual recommendations for monitoring or safety considerations related to renal impairment (kidney issues) are not provided.

Always consult your healthcare provider for personalized advice and to ensure that any medications you take are safe and appropriate for your kidney health. They can help you understand how your condition may affect your treatment plan.

Hepatic Impairment

If you have liver problems, it's important to know that there are no specific guidelines or dosage adjustments mentioned for your condition in the available information. This means that the standard recommendations apply, but you should always consult your healthcare provider for personalized advice. They can help monitor your liver function and determine the best approach for your treatment.

Make sure to keep your doctor informed about your liver health, as they may need to conduct regular tests to ensure your safety while using any medication. Your well-being is a priority, so don't hesitate to ask questions or express any concerns you may have.

Drug Interactions

It's important to be aware that antacids, which are commonly used to relieve heartburn and indigestion, can interact with some prescription medications. This means that taking antacids at the same time as certain drugs could affect how well those medications work.

To ensure your safety and the effectiveness of your treatment, always discuss any medications you are taking, including over-the-counter products like antacids, with your healthcare provider. They can help you understand potential interactions and adjust your treatment plan if necessary.

Storage and Handling

To ensure the best performance of your product, store it at a temperature of 25°C (77°F). It can safely be kept within a range of 15°-30°C (59°-86°F), but try to avoid exposing it to excessive humidity. Always check the end flap for the expiration date and lot number to confirm its safety and effectiveness.

When handling the product, be mindful of these storage conditions to maintain its quality. Proper storage and attention to the expiration details will help ensure that you use the product safely and effectively.

Additional Information

You should take this medication orally. If your child is currently taking any prescription drugs, it's important to consult with a doctor or pharmacist before using this medication, as antacids can interact with certain prescriptions. If symptoms persist for more than two weeks, stop using the medication and seek medical advice. Always keep this and all medications out of the reach of children to ensure their safety.

FAQ

What is DG™ | health?

DG™ | health is a children's antacid that contains 400 mg of Calcium Carbonate in chewable tablet form.

What symptoms does DG™ | health relieve?

It relieves acid indigestion, heartburn, sour stomach, and upset stomach associated with these symptoms.

How should I take DG™ | health?

You should chew or crush the tablets completely before swallowing; do not swallow them whole.

What is the maximum dosage for children?

Do not take more than 3 chewable tablets for ages 2-5 or 6 chewable tablets for ages 6-11 in a 24-hour period.

What should I do if symptoms last more than two weeks?

Stop use and ask a doctor if symptoms last more than two weeks.

Are there any warnings for using DG™ | health?

Yes, ask a doctor or pharmacist before use if the child is taking a prescription drug, as antacids may interact with certain medications.

How should I store DG™ | health?

Store at 25°C (77°F) and avoid excessive humidity. Check the end flap for the expiration date and lot number.

Is there any information about using DG™ | health during pregnancy or lactation?

No specific information regarding use during pregnancy or lactation is provided.

What flavor does DG™ | health have?

DG™ | health has a bubble gum flavor.

What should I do if the safety seal is broken or missing?

Do not use the product if the tamper evident safety seal under the cap is broken or missing.

Packaging Info

Below are the non-prescription pack sizes of Childrens Antacid (calcium carbonate). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Packaging configurations for Childrens Antacid.
Details

Drug Information (PDF)

This file contains official product information for Childrens Antacid, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)

Description

DG™ | health is a children's antacid formulation designed to relieve symptoms associated with acid indigestion, heartburn, sour stomach, and upset stomach. Each chewable tablet contains 400 mg of calcium carbonate as the active ingredient. The product is presented in a chewable tablet dosage form, with a total quantity of 24 tablets per package. The tablets are flavored with bubble gum to enhance palatability.

Administration requires that the tablets be chewed or crushed completely before swallowing. The product features a tamper-evident safety seal; it should not be used if the seal under the cap is broken or missing. This product is not manufactured or distributed by The Procter & Gamble Company, the owner of the registered trademark Pepto® Kids Chewables.

Uses and Indications

This drug is indicated for the relief of heartburn, acid indigestion, sour stomach, and upset stomach associated with these symptoms.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

Healthcare professionals should determine the appropriate dose based on the patient's weight, which is the preferred method. If weight is not available, age may be used as an alternative.

For patients weighing under 24 pounds or under 2 years of age, it is recommended to consult a physician for dosing guidance. For patients weighing between 24 and 47 pounds (ages 2-5), the recommended dose is 1 chewable tablet. For those weighing between 48 and 95 pounds (ages 6-11), the recommended dose is 2 chewable tablets.

Patients should chew or crush the tablets completely before swallowing; the tablets should not be swallowed whole. Doses may be repeated as needed, but it is important to adhere to the following maximum dosage limits: do not exceed 3 chewable tablets for patients aged 2-5 or 6 chewable tablets for patients aged 6-11 within a 24-hour period. Additionally, the maximum dosage should not be used for more than two weeks unless directed and supervised by a physician.

Contraindications

There are no specific contraindications listed for this product. However, it is advised to discontinue use and consult a healthcare professional if symptoms persist for more than two weeks.

Warnings and Precautions

Healthcare professionals are advised to exercise caution when recommending this product, particularly in pediatric populations. It is imperative to consult with a physician or pharmacist prior to administration if the child is currently taking any prescription medications, as antacids may have the potential to interact with certain drugs.

In cases where symptoms persist beyond a duration of two weeks, it is essential to discontinue use and seek medical advice. This precaution is critical to ensure that underlying conditions are appropriately evaluated and managed.

While no specific emergency medical instructions are provided, healthcare professionals should remain vigilant and prepared to address any adverse reactions or complications that may arise during treatment.

Currently, there are no specific laboratory tests or monitoring parameters indicated for the safe use of this product. However, ongoing assessment of the patient's overall health and response to treatment is recommended to ensure optimal outcomes.

Side Effects

Patients should be advised to consult a doctor or pharmacist prior to use if they are currently taking a prescription drug, as antacids may interact with certain medications.

In the event that symptoms persist for more than two weeks, patients are instructed to discontinue use and seek medical advice.

It is crucial to keep this medication, along with all other drugs, out of the reach of children to prevent accidental ingestion and potential harm.

Drug Interactions

Antacids may interact with various prescription medications, potentially affecting their absorption and efficacy. It is advisable to monitor the timing of antacid administration in relation to other medications to minimize these interactions. Specifically, antacids should be taken at least 2 hours apart from other drugs to ensure optimal therapeutic effects and to avoid diminished efficacy of the prescribed treatment.

Packaging & NDC

Below are the non-prescription pack sizes of Childrens Antacid (calcium carbonate). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Packaging configurations for Childrens Antacid.
Details

Pediatric Use

Pediatric patients should be advised to consult a doctor or pharmacist before using this product if they are currently taking any prescription medications, as antacids may interact with certain drugs. It is important to discontinue use and seek medical advice if symptoms persist for more than two weeks.

Care should be taken to keep this and all medications out of the reach of children. Dosing should be determined based on weight whenever possible; otherwise, age may be used as a guide. The following dosing recommendations apply: for children under 24 lb and under 2 years of age, consultation with a doctor is necessary. For those weighing 24-47 lb (ages 2-5), the recommended dose is 1 chewable tablet. For children weighing 48-95 lb (ages 6-11), the recommended dose is 2 chewable tablets.

Patients should chew or crush the tablets completely before swallowing; whole tablets should not be swallowed. Doses may be repeated as needed, but it is crucial not to exceed 3 chewable tablets for ages 2-5 or 6 chewable tablets for ages 6-11 within a 24-hour period. Additionally, the maximum dosage should not be used for more than two weeks unless directed and supervised by a physician.

Geriatric Use

There is no specific information available regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. It is advisable to monitor these patients closely for any adverse effects or changes in efficacy.

Pregnancy

There is no specific information regarding the use of this medication during pregnancy, including safety concerns, dosage modifications, or special precautions. Healthcare professionals should consider the lack of data when prescribing this medication to pregnant patients. The potential risks and benefits should be carefully evaluated, and alternative treatments may be considered in consultation with the patient. Women of childbearing potential should be advised to discuss their pregnancy status and any plans for pregnancy with their healthcare provider prior to initiating treatment.

Lactation

There is no specific information available regarding the use of this medication in nursing mothers or its effects on lactation. Consequently, healthcare professionals should exercise caution when considering this medication for lactating mothers, as the potential risks and benefits have not been established. Breastfed infants may be affected by the absence of data on excretion in breast milk and the potential impact on their health. It is advisable to monitor breastfed infants for any adverse effects if the medication is administered to lactating mothers.

Renal Impairment

There is no specific information available regarding dosage adjustments, special monitoring, or safety considerations for patients with renal impairment. Healthcare professionals should exercise caution when prescribing to patients with reduced kidney function, as the absence of detailed guidance necessitates careful clinical judgment. Regular monitoring of renal function may be advisable in these patients to ensure safety and efficacy.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the absence of specific information regarding overdosage, healthcare professionals are advised to exercise caution and adhere to general principles of management in cases of suspected overdose.

It is essential to monitor the patient closely for any potential symptoms that may arise from an overdose. Symptoms can vary widely depending on the substance involved and the individual patient's response.

In the event of an overdose, immediate medical attention should be sought. Healthcare providers should implement supportive care measures, which may include monitoring vital signs, providing symptomatic treatment, and ensuring the patient's safety.

If available, consultation with a poison control center or a medical toxicologist is recommended to guide the management of the overdose effectively.

Documentation of the incident, including the substance involved, the amount taken, and the time of ingestion, is crucial for appropriate treatment and follow-up care.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in these contexts.

Postmarketing Experience

No postmarketing experience details are available for SPL code 90375-7.

Patient Counseling

Healthcare providers should advise patients to keep this medication and all other drugs out of the reach of children to prevent accidental ingestion.

Patients should be informed to discontinue use and consult a doctor if their symptoms persist for more than two weeks, as this may indicate a need for further evaluation or a change in treatment.

Additionally, it is important for healthcare providers to recommend that patients consult with a doctor or pharmacist before using this medication if the child is currently taking any prescription drugs. This is particularly crucial as antacids may interact with certain prescription medications, potentially affecting their efficacy or safety.

Storage and Handling

The product is supplied in configurations that include specific NDC numbers, which can be found on the packaging. It should be stored at a controlled room temperature of 25°C (77°F), with permissible excursions between 15°C and 30°C (59°F to 86°F). Care should be taken to avoid excessive humidity during storage. For additional information regarding the expiration date and lot number, please refer to the end flap of the packaging.

Additional Clinical Information

The route of administration for the medication is oral. Clinicians should advise patients to consult a doctor or pharmacist prior to use if the child is currently taking any prescription medications, as antacids may interact with certain drugs. Patients are also instructed to discontinue use and seek medical advice if symptoms persist for more than two weeks. Additionally, it is important to keep this and all medications out of the reach of children.

Drug Information (PDF)

This file contains official product information for Childrens Antacid, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)

Data Generation & Sources

This page was automatically generated and is maintained by the AllDrugs AI Data-Science Team. It was built from the FDA Structured Product Label (DailyMed) for Childrens Antacid, retrieved by a validated AI data-extraction workflow.

All FDA-listed dosage forms and strengths are shown in the Packaging & NDC Codes section above. Regulatory status appears in the Summary Information panel above and was verified in the FDA National Drug Code directory and the NSDE NDC Directory daily file.

Note: an automated daemon monitors NSDE checksums; when the record for this NDC changes, the new file is pulled instantly and this page is refreshed.

No human clinician has reviewed this version.

Learn more in our Editorial Policy

Last AI update:

Primary FDA sources:

Orange Book data shown on this page are limited to Regulatory Status (Rx), Established Pharmacologic Class (EPC), and Mechanism of Action (MoA).

Regulatory data notice: Information on this page is reproduced verbatim from FDA public databases (NSDE, Orange Book, Purple Book, DailyMed SPL). NDA/ANDA drugs are FDA-approved, BLA biologics are FDA-licensed. Inclusion alone does not guarantee current market availability or imply FDA endorsement.

Medical disclaimer: This AI-generated content is provided for educational purposes only and does not constitute medical advice. Always consult a licensed healthcare professional for diagnosis or treatment decisions.